Literature DB >> 26392034

Reconstruction and analysis of a genome-scale metabolic network of Corynebacterium glutamicum S9114.

Jie Mei1, Nan Xu1, Chao Ye1, Liming Liu2, Jianrong Wu3.   

Abstract

Corynebacterium glutamicum S9114 is commonly used for industrial glutamate production. Therefore, a comprehensive understanding of the physiological and metabolic characteristics of C. glutamicum is important for developing its potential for industrial production. A genome-scale metabolic model, iJM658, was reconstructed based on genome annotation and literature mining. The model consists of 658 genes, 984 metabolites and 1065 reactions. The model quantitatively predicted C. glutamicum growth on different carbon and nitrogen sources and determined 129 genes to be essential for cell growth. The iJM658 model predicted that C. glutamicum had two glutamate biosynthesis pathways and lacked eight key genes in biotin synthesis. Robustness analysis indicated a relative low oxygen level (1.21mmol/gDW/h) would improve glutamate production rate. Potential metabolic engineering targets for improving γ-aminobutyrate and isoleucine production rate were predicted by in silico deletion or overexpression of some genes. The iJM658 model is a useful tool for understanding and optimizing the metabolism of C. glutamicum and a valuable resource for future metabolic and physiological research.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Corynebacterium glutamicum S9114; Genome-scale metabolic model; l-Glutamate production; l-Isoleucine production; γ-Aminobutyrate production

Mesh:

Substances:

Year:  2015        PMID: 26392034     DOI: 10.1016/j.gene.2015.09.038

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  9 in total

1.  Overexpression of ppc or deletion of mdh for improving production of γ-aminobutyric acid in recombinant Corynebacterium glutamicum.

Authors:  Feng Shi; Ming Zhang; Yongfu Li
Journal:  World J Microbiol Biotechnol       Date:  2017-05-22       Impact factor: 3.312

2.  Improvement of l-arginine production by in silico genome-scale metabolic network model guided genetic engineering.

Authors:  Mingzhu Huang; Yue Zhao; Rong Li; Weihua Huang; Xuelan Chen
Journal:  3 Biotech       Date:  2020-02-19       Impact factor: 2.406

3.  Pathway engineering in Corynebacterium glutamicum S9114 for 5-aminolevulinic acid production.

Authors:  Bin Zhang; Bang-Ce Ye
Journal:  3 Biotech       Date:  2018-05-08       Impact factor: 2.406

4.  Systematic pathway engineering of Corynebacterium glutamicum S9114 for L-ornithine production.

Authors:  Bin Zhang; Miao Yu; Ying Zhou; Yixue Li; Bang-Ce Ye
Journal:  Microb Cell Fact       Date:  2017-09-22       Impact factor: 5.328

5.  A new genome-scale metabolic model of Corynebacterium glutamicum and its application.

Authors:  Yu Zhang; Jingyi Cai; Xiuling Shang; Bo Wang; Shuwen Liu; Xin Chai; Tianwei Tan; Yun Zhang; Tingyi Wen
Journal:  Biotechnol Biofuels       Date:  2017-06-30       Impact factor: 6.040

6.  Growth-coupled overproduction is feasible for almost all metabolites in five major production organisms.

Authors:  Axel von Kamp; Steffen Klamt
Journal:  Nat Commun       Date:  2017-06-22       Impact factor: 14.919

7.  Development of a DNA double-strand break-free base editing tool in Corynebacterium glutamicum for genome editing and metabolic engineering.

Authors:  Chen Deng; Xueqin Lv; Jianghua Li; Yanfeng Liu; Guocheng Du; Long Liu
Journal:  Metab Eng Commun       Date:  2020-06-01

8.  Metabolic engineering of Corynebacterium glutamicum S9114 based on whole-genome sequencing for efficient N-acetylglucosamine synthesis.

Authors:  Chen Deng; Xueqin Lv; Yanfeng Liu; Jianghua Li; Wei Lu; Guocheng Du; Long Liu
Journal:  Synth Syst Biotechnol       Date:  2019-06-06

9.  GeneReg: a constraint-based approach for design of feasible metabolic engineering strategies at the gene level.

Authors:  Zahra Razaghi-Moghadam; Zoran Nikoloski
Journal:  Bioinformatics       Date:  2021-07-19       Impact factor: 6.937

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.